Czynniki prognostyczne u chorych na czerniaka z przerzutami do mozgu

Abstract

Author(s): Ewa Jakubowicz, Tomasz Walasek, Marian Reinfuss, Jerzy Jakubowicz, Pawel Blecharz, Bogumila Szyszka- Charewicz

On the basis of the literature it has been presented prognostic factors for overall survivals of patients with brain metastases of malignant melanoma. Most often factors mentioned by authors are: performance status, extracerebral metastases, number of brain metastases, age and primary tumor control. In addition, in the years 2010-2013, the analysis of large groups of patients, revealed that pretreatment serum lactase dehydrogenase (LDH) level also remained as significant prognostic factor.

Share this article

Editors List

  • S.SREEDHAR

    Submitted PhD thesis in Biotechnology at GITAM University, Vizag.

  • Yousef Alomi

    Yousef Alomi
    The Past Head, General Administration of Pharmaceutical Care at Ministry of Health,
    Saudi Arabia Critical Care/TPN
    Clinical Pharmacist Ministry of Health,
    Riyadh, Saudi Arabia.

  • Osamu Tanaka

    Osamu Tanaka
    Assistant Professor,
    Department of Radiation Oncology
    Asahi University Hospital
    Gifu city, Gifu, Japan

  • Maher Abdel Fattah Al-Shayeb

    Department of Surgical Sciences, Ajman University, UAE

  • Andrzej Zdziennicki

    Institute of Gynecology and Obstetrics, Medical University of Lodz, I Clinic of Gynecology and Gynecological Oncology (Lodz, Poland)

Google Scholar citation report
Citations : 61

Onkologia i Radioterapia received 61 citations as per Google Scholar report

Onkologia i Radioterapia peer review process verified at publons
Indexed In
  • Scimago
  • SCOPUS
  • MIAR
  • Euro Pub
  • Google Scholar
  • Medical Project Poland
  • PUBMED
  • Cancer Index
  • Gdansk University of Technology, Ministry Points 20